Novartis AG Other Operating Income or Expenses 2012-2026 | NVS
Novartis AG other operating income or expenses for the twelve months ending March 31, 2026 were $-0.527B, a 68.61% decline year-over-year.
- Novartis AG annual other operating income or expenses for 2025 were $-0.883B, a 49.91% decline from 2024.
- Novartis AG annual other operating income or expenses for 2024 were $-1.763B, a 232.02% increase from 2023.
- Novartis AG annual other operating income or expenses for 2023 were $-0.531B, a 79.32% decline from 2022.